EUVIMEDEUVIMED entdecken
Crossref

Method Development And Validation For Estimation Of Related Substances In Selpercatinib Bulk Dosage Form By Rp-Hplc Technique

Mr. Suraj P. Rajurkar, Mr. Salman Ahmad Khan, Mr. Shivprasad Sanjay Dhage, Mr. Tokhirmalik Okhunjonov, Dr. Karishma A. Nikose, Prof. Suraj D. Thakare, Prof.Ruchika V. Gawande, Miss Khemutai Gajanan Shedame

International Journal of Drug Delivery Technology · 18.05.2026 · 16 (28s)

DOI: 10.25258/ijddt.16.28s.4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 18.05.2026. Verfasst von Mr. Suraj P. Rajurkar und 7 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study focuses on the development and validation of a high-performance liquid chromatography (HPLC) method for the quantification of process-related impurities (Impurity A and Impurity B) in Selpercatinib. The optimized chromatographic conditions employed a gradient-mode HPLC-PDA system using an Inertsil C18 column (250 × 4.6 mm, 5 μm). The mobile phase consisted of sodium dihydrogen phosphate buffer (NaH₂PO₄) adjusted to pH 4, combined with methanol. The flow rate was maintained at 1.0 mL/min, and detection was carried out at 238 nm. The method was validated in accordance with standard parameters including linearity, precision, accuracy, robustness, and forced degradation studies. Linearity demonstrated excellent correlation coefficients (r² > 0.999) across the specified concentration ranges. Precision studies showed low variability, with %RSD values below 2%, confirming the method’s reproducibility. Accuracy results indicated satisfactory recovery, ranging from 98–102% for Selpercatinib and 90–110% for the impurities, demonstrating the method’s reliability in quantification. Degradation studies further confirmed the stability-indicating capability of the method, supporting its suitability for routine quality control and stability assessment. Overall, the developed method provides a robust, precise, and reliable analytical approach for ensuring the purity of Selpercatinib and compliance with regulatory requirements in pharmaceutical analysis.

Zitieren

APA

Rajurkar, M. S. P., Khan, M. S. A., Dhage, M. S. S., Okhunjonov, M. T., Nikose, D. K. A., Thakare, P. S. D., Gawande, P. V., & Shedame, M. K. G. (2026). Method Development And Validation For Estimation Of Related Substances In Selpercatinib Bulk Dosage Form By Rp-Hplc Technique. International Journal of Drug Delivery Technology, 16(28s). https://doi.org/10.25258/ijddt.16.28s.4

Vancouver

Rajurkar MSP, Khan MSA, Dhage MSS, Okhunjonov MT, Nikose DKA, Thakare PSD, et al. Method Development And Validation For Estimation Of Related Substances In Selpercatinib Bulk Dosage Form By Rp-Hplc Technique. International Journal of Drug Delivery Technology. 2026;16(28s). doi:10.25258/ijddt.16.28s.4

BibTeX
@article{Rajurkar2026,
  author = {Rajurkar, Mr. Suraj P. and Khan, Mr. Salman Ahmad and Dhage, Mr. Shivprasad Sanjay and Okhunjonov, Mr. Tokhirmalik and Nikose, Dr. Karishma A. and Thakare, Prof. Suraj D. and Gawande, Prof.Ruchika V. and Shedame, Miss Khemutai Gajanan},
  title = {Method Development And Validation For Estimation Of Related Substances In Selpercatinib Bulk Dosage Form By Rp-Hplc Technique},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {28s},
  doi = {10.25258/ijddt.16.28s.4}
}
Kostenlos starten →